Page last updated: 2024-11-03

pyridinolcarbamate and Gastroduodenal Ulcer

pyridinolcarbamate has been researched along with Gastroduodenal Ulcer in 1 studies

Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)

Research Excerpts

ExcerptRelevanceReference
"The use of HBO in the treatment of peptic ulcer raised the efficacy of the multimodality therapy and accelerated the epithelization of erosive and ulcerative defects."1.28[Evaluation of the therapeutic effect of hyperbaric oxygenation and anginin in peptic ulcer]. ( Chorbinskaia, SA; Elizavetina, GA; Izmalkova, NM; Vinnitskiĭ, LI; Vorob'eva, NT, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elizavetina, GA1
Vinnitskiĭ, LI1
Vorob'eva, NT1
Chorbinskaia, SA1
Izmalkova, NM1

Other Studies

1 other study available for pyridinolcarbamate and Gastroduodenal Ulcer

ArticleYear
[Evaluation of the therapeutic effect of hyperbaric oxygenation and anginin in peptic ulcer].
    Terapevticheskii arkhiv, 1989, Volume: 61, Issue:2

    Topics: Aged; Anti-Ulcer Agents; Carbamates; Combined Modality Therapy; Cyclic AMP; Cyclic GMP; Female; Gast

1989